KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Cost of Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Cost of Revenue for 12 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 2.58% to $1.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.4 million, a 1.35% decrease, with the full-year FY2024 number at $4.3 million, down 30.27% from a year prior.
  • Cost of Revenue was $1.0 million for Q3 2025 at Precigen, down from $1.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $5.6 million in Q1 2021 to a low of -$1.7 million in Q4 2021.
  • A 5-year average of $1.5 million and a median of $1.2 million in 2024 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: tumbled 86.5% in 2021, then surged 377.52% in 2022.
  • Precigen's Cost of Revenue stood at -$1.7 million in 2021, then skyrocketed by 377.52% to $4.8 million in 2022, then tumbled by 71.43% to $1.4 million in 2023, then fell by 13.92% to $1.2 million in 2024, then fell by 11.46% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Cost of Revenue are $1.0 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).